Related Experiment Videos
Early thrombolytic treatment in acute coronary thrombosis
1School of Medicine, Medical Professorial Unit, University of New South Wales, St Vincent's Hospital, Sydney.
Insights
Prompt treatment for acute myocardial infarction is crucial. Delays in thrombolysis reduce its effectiveness, highlighting the need for public education and rapid hospital care to minimize irreversible heart damage.
Area of Science:
- Cardiology
- Emergency Medicine
Background:
- Acute myocardial infarction (AMI) begins with coronary artery occlusion due to atherosclerotic plaque rupture.
- This leads to thrombus formation, causing myocardial ischemia and potentially irreversible infarction within hours.
Purpose of the Study:
- To emphasize the critical need for timely intervention in acute myocardial infarction.
- To highlight the impact of treatment delays on patient outcomes and the potential benefits of minimizing these delays.
Main Methods:
- Review of established understanding of AMI pathophysiology and thrombolysis.
- Analysis of treatment timelines and their correlation with therapeutic effectiveness.
Main Results:
- Irreversible myocardial damage begins within 30 minutes of occlusion and is extensive by six hours.
- Thrombolytic therapy is most effective when administered within six hours of symptom onset.
- Current delays in initiating thrombolysis (average 4 hours) significantly reduce treatment benefits.
Conclusions:
- Minimizing delays in diagnosis and treatment is essential for improving outcomes in acute myocardial infarction.
- Public education on AMI symptoms and prompt hospital assessment are critical for effective, rapid management.
Abstract:
It is now accepted that the earliest event in acute myocardial infarction is coronary occlusion caused by fissuring of an atherosclerotic plaque, with resultant platelet deposition on the mural flaw and build up of thrombus within the lumen. The symptoms generated are caused by myocardial ischaemia, as first described by Herrick and Levine some 80 years ago. If occlusion is not relieved, irreversible damage (infarction) begins in the ischaemic region within 30 minutes, is half completed by 2.5 hours, and is virtually completed by six hours. Thrombolysis is now accepted therapy for acute evolving myocardial infarction, but in most cases such therapy is not commenced for four hours after symptom onset, when most of the irreparable damage has already been done and when the potential for benefit has fallen substantially. The average time to thrombolysis in GUSTO worldwide, however, was two hours and, in Australia, 2.8 hours. Only patients who could be submitted to thrombolysis within six hours of the onset of pain were included. The results of thrombolytic therapy in acute thrombosis are likely to be improved if delays are minimised. This requires education of the public in the symptoms of this condition, and on the actions to take if such symptoms arise. It also requires expeditious transfer to hospital (or appropriate treatment outside) and above all it requires expeditious assessment and treatment when patients arrive in hospital. Use of the diagnosis 'myocardial infarction' for such patients implies that irreversible damage has already occurred and serves as a disincentive for the speedy, aggressive management that is logical and appropriate for dissolution of the offending coronary thrombus.